Form 8-K - Current report:
SEC Accession No. 0000950123-09-054627
Filing Date
2009-10-29
Accepted
2009-10-29 10:41:19
Documents
3
Period of Report
2009-10-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d69814e8vk.htm 8-K 11966
2 EX-99.1 d69814exv99w1.htm EX-99.1 40987
3 GRAPHIC d69814d6981402.gif GRAPHIC 3280
  Complete submission text file 0000950123-09-054627.txt   59197
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 091143544
SIC: 2836 Biological Products, (No Diagnostic Substances)